AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CME GROUP INC. Director's Dealing 2025

Mar 18, 2025

29871_dirs_2025-03-18_a84d4f4b-5f00-4561-b8f6-14403b4e73a4.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CME GROUP INC. (CME)
CIK: 0001156375
Period of Report: 2025-03-15

Reporting Person: Piell Hilda Harris (Sr MD & Chief HR Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-03-15	Common Stock Class A	A	3451	$258.68	Acquired	30497	Direct
2025-03-15	Common Stock Class A	F	1436	$258.68	Disposed	29061	Direct

Footnotes

F1: For the PSAs granted in September 2021: Represents shares earned from a 2021 performance share award based on the company's achievement of total shareholder return relative to the S&P 500 measured over 2022-2024.

F2: Ms. Piell surrendered shares to the Company in order to fulfill tax withholding obligations in connection with the receipt of the performance share award.